Back to Search
Start Over
TGF-β-induced IGFBP-3 is a key paracrine factor from activated pericytes that promotes colorectal cancer cell migration and invasion
- Source :
- Navarro, R, Tapia-Galisteo, A, Martín-García, L, Tarín, C, Corbacho, C, Gómez-López, G, Sánchez-Tirado, E, Campuzano, S, González-Cortés, A, Yáñez-Sedeño, P, Compte, M, Álvarez-Vallina, L & Sanz, L 2020, ' TGF-β-induced IGFBP-3 is a key paracrine factor from activated pericytes that promotes colorectal cancer cell migration and invasion ', Molecular Oncology, vol. 14, no. 10, pp. 2609-2628 . https://doi.org/10.1002/1878-0261.12779, Repisalud, Instituto de Salud Carlos III (ISCIII), Molecular Oncology, Molecular Oncology, Vol 14, Iss 10, Pp 2609-2628 (2020)
- Publication Year :
- 2020
-
Abstract
- In this work, we show that TGF‐β produced by colorectal cancer cells activates pericytes that in turn promote their tumorigenic properties through the release of soluble factors, including IGFBP‐3, with a prominent role in cancer cell migration and invasion. Moreover, co‐implantation of colorectal cancer cells and pericytes in immunodeficient mice increased tumor growth.<br />The crosstalk between cancer cells and the tumor microenvironment has been implicated in cancer progression and metastasis. Fibroblasts and immune cells are widely known to be attracted to and modified by cancer cells. However, the role of pericytes in the tumor microenvironment beyond endothelium stabilization is poorly understood. Here, we report that pericytes promoted colorectal cancer (CRC) cell proliferation, migration, invasion, stemness, and chemoresistance in vitro, as well as tumor growth in a xenograft CRC model. We demonstrate that coculture with human CRC cells induced broad transcriptomic changes in pericytes, mostly associated with TGF‐β receptor activation. The prognostic value of a TGF‐β response signature in pericytes was analyzed in CRC patient data sets. This signature was found to be a good predictor of CRC relapse. Moreover, in response to stimulation by CRC cells, pericytes expressed high levels of TGF‐β1, initiating an autocrine activation loop. Investigation of secreted mediators and underlying molecular mechanisms revealed that IGFBP‐3 is a key paracrine factor from activated pericytes affecting CRC cell migration and invasion. In summary, we demonstrate that the interplay between pericytes and CRC cells triggers a vicious cycle that stimulates pericyte cytokine secretion, in turn increasing CRC cell tumorigenic properties. Overall, we provide another example of how cancer cells can manipulate the tumor microenvironment.
- Subjects :
- 0301 basic medicine
Cancer Research
Carcinogenesis
Metastasis
0302 clinical medicine
Cell Movement
Transforming Growth Factor beta
pericyte
Research Articles
Cell migration
General Medicine
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
medicine.anatomical_structure
Phenotype
Oncology
030220 oncology & carcinogenesis
Neoplastic Stem Cells
Molecular Medicine
Female
Pericyte
Colorectal Neoplasms
Research Article
Signal Transduction
TGF-β
Mice, Nude
colorectal cancer
Biology
lcsh:RC254-282
03 medical and health sciences
Paracrine signalling
Cell Line, Tumor
Paracrine Communication
Genetics
medicine
Animals
Humans
tumor microenvironment
Neoplasm Invasiveness
Autocrine signalling
TGF‐β
Cell Proliferation
Tumor microenvironment
IGFBP-3
medicine.disease
IGFBP‐3
digestive system diseases
030104 developmental biology
Insulin-Like Growth Factor Binding Protein 3
Drug Resistance, Neoplasm
Cancer cell
Cancer research
Cytokine secretion
Pericytes
Proto-Oncogene Proteins c-akt
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Navarro, R, Tapia-Galisteo, A, Martín-García, L, Tarín, C, Corbacho, C, Gómez-López, G, Sánchez-Tirado, E, Campuzano, S, González-Cortés, A, Yáñez-Sedeño, P, Compte, M, Álvarez-Vallina, L & Sanz, L 2020, ' TGF-β-induced IGFBP-3 is a key paracrine factor from activated pericytes that promotes colorectal cancer cell migration and invasion ', Molecular Oncology, vol. 14, no. 10, pp. 2609-2628 . https://doi.org/10.1002/1878-0261.12779, Repisalud, Instituto de Salud Carlos III (ISCIII), Molecular Oncology, Molecular Oncology, Vol 14, Iss 10, Pp 2609-2628 (2020)
- Accession number :
- edsair.doi.dedup.....8b5301b9a8720dd239a2a206e6ef9f75
- Full Text :
- https://doi.org/10.1002/1878-0261.12779